Company intelligence / Profile preview

Refarmed Chemicals

Ownership: Private
Development stage: Other

Overview

Refarmed Chemicals is a Swiss-based distributor with more than 40 years of experience in active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs), specializing in supporting the generic pharmaceutical industry and regulatory filings. In 2022, it was acquired by DKSH Group and integrated into their Market Expansion Services[1][2][3].

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Partnerships

DKSH Group (acquirer/strategic partner)

Beyond the preview

Go deeper on Refarmed Chemicals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Refarmed Chemicals.